Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sarepta Therapeutics Inc (NASDAQ:SRPT)

29.80
Delayed Data
As of Mar 28
 -0.76 / -2.49%
Today’s Change
8.00
Today|||52-Week Range
63.73
+8.64%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Revenue and IncomeNet Revenues0.000.000.005.4M
 
 
Cost of Goods Sold0.000.000.00130.0K
 
 
Depreciation And Amortization1.4M1.5M1.1M1.7M
 
 
 
 
 
 
Operating ExpensesGross Income-1.4M-1.5M-1.1M3.6M
 
 
 
 
 
General Expenses57.8M60.0M54.2M92.0M
 
 
 
 
 
Research And Development38.3M43.8M33.6M70.7M
 
 
 
 
 
Total Operating Expenses59.2M61.5M55.3M93.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-59.2M-61.5M-55.3M-88.4M
 
 
 
 
 
Extraordinary Charge-533.0K-626.0K-1.3M0.00
 
 
 
 
Interest Expense On Debt68.0K201.0K209.0K57.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-59.8M-62.3M-56.7M-88.5M
 
 
 
 
 
Net Income-59.8M-62.3M-56.7M-88.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS45.7M46.2M48.3M54.6M
 
 
 
 
 
Shares To Calculate EPS Diluted45.7M46.2M48.3M54.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.31-$1.35-$1.18-$1.62
 
 
 
 
 
EPS Diluted-$1.31-$1.35-$1.18-$1.62